To evaluate the role of two different approaches to perform laparoscopic RPLND: transperitoneal laparoscopic retroperitoneal lymph node dissection (TL-RPLND) and extraperitoneal laparoscopic retroperitoneal lymph node dissection (EL-RPLND).
Materials and methods
Between February 2003 and April 2013, 39 patients with nonseminomatous germ cell testicular tumors were treated by RPLND in our center. Twenty-one patients had TL-RPLND, and 18 patients had EL-RPLND. We performed a comprehensive retrospective study comparing TL-RPLND and EL-RPLND. Certain parameters, including operative time, estimated blood loss, perioperative complications, resected lymph nodes, postoperative intestinal function recovery time, ejaculation, and postoperative tumor markers, were abstracted and compared.
In the EL-RPLND and TL-RPLND groups, the operation times were 178 ± 31 and 207 ± 25 min; the amounts of estimated blood loss were 87 ± 26 and 111 ± 21 ml; the postoperative intestinal function recovery times were 1.2 ± 0.7 and 2.4 ± 0.6 days; the postoperative hospital stays were 5.8 ± 1.1 and 5.5 ± 1.4 days; and the numbers of resected lymph nodes were 16.2 ± 1.5 and 15.8 ± 1.6, respectively. No conversion from laparoscopic to open surgery occurred. No patient in either group received an intraoperative blood transfusion. Overall, two patients developed postoperative fever, and one developed abdominal distension. After a median follow-up of 45 months, no regional relapse or metastases occurred, but 4 patients at clinical stage II were treated successfully by three cycles of platinum-based postoperative chemotherapy. Currently, all patients show no evidence of disease.
Our results demonstrate that EL-RPLND was superior to the transperitoneal approach in terms of the operation time, estimated blood loss, and postoperative intestinal function recovery time, whereas no differences were observed in the number of lymph nodes resected. EL-RPLND was demonstrated to be safe and feasible, with satisfactory clinical outcomes when performed by experienced laparoscopic surgeons. Larger cohorts of patients with longer term follow-up are needed for further studies to determine the role of different approaches to L-RPLND.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Hayes-Lattin B, Nichols CR (2009) Testicular cancer: a prototypic tumor of young adults. Semin Oncol 36(5):432–438
Yuvaraja TB (2012) Current update of management of clinical stage I non seminomatous germ cell tumors of testis. Indian J Surg Oncol 3(2):101–106
LeBlanc E, Caty A et al (2001) Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results. J Urol 165(1):89–92
Skolarus TA, Bhayani SB et al (2008) Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer. J Endourol 22(7):1485–1489
LeBlanc A, Caty A, Dargent D et al (2001) Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results. J Urol 165:89–92
Davol P, Sumfest J, Rukstalis D (2006) Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 67:199
Qin C, Meng X et al (2011) Extraperitoneal laparoscopic retroperitoneal lymph node dissection. J Endourol Part B Videourology. doi:10.1089/vid.2010.0094
Sesterhenn IA, Davis CJ Jr (2004) Pathology of germ cell tumors of the testis. Cancer Control 11(6):374–387
Rukstalis DB, Chodak GW (1992) Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol 148(6):1907-9; discussion 1909-10
Suer E, Mermerkaya M et al (2013) Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor? J Urol. http://dx.doi.org/10.1016/j.juro.2013.06.009, http://www.sciencedirect.com/science/article/pii/S0022534713045722. ISSN 0022-5347
Heinzelbecker J, Katzmarzik M et al (2013) During twenty years of Cisplatin-based therapy the face of nonseminomatous testicular germ cell tumors is still changing: an evaluation of presentation, management, predictive factors and survival. Int Braz J Urol 39(1):10–21
Oldenburg J, Alfsen GC, Lien HH et al (2003) Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 21(17):3310–3317
Foster R, Bihrle R (2002) Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate. Cancer Control 9(4):277–283
Ozen H, Ekici S et al (2001) Resection of residual masses alone: an alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy. Urology 57(2):323–327
Lv ZJ, Wu S et al (2013) Clinical outcomes in patients with stage I non-seminomatous germ cell cancer. Asian J Androl 15(4):558–563
Heidenreich A, Pfister D (2012) Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice. Ther Adv Urol 4(4):187–205
Dash A, Carver BS et al (2008) The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor. Cancer 112(4):800–805
Nonomura N, Nishimura K et al (2002) Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy. Int J Urol 9(10):539–544
Liu ZW et al (2008) Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors. Ai Zheng 27(12):1302–1306
Carver BS et al (2010) The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer. Urology 75(6):1431–1435
Hudolin T et al (2012) Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors. Int J Surg Pathol 20(1):15–18
Arai Y, Kaiho Y et al (2012) Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes. Int Urol Nephrol 44(5):1389–1395
Sherwood JB et al (2003) Laparoscopic retroperitoneal lymph node dissection in the extremely obese patient: technical insight into access and port placement. JSLS 7(3):265–267
Albers P et al (2012) EAU guidelines on testicular cancer: 2011 update. European Association of Urology. Actas Urol Esp 36(3):127–145
Djaladat H, Nichols C et al (2012) Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Ann Surg Oncol 19(7):2388–2393
Lattouf JB, Jeschke S et al (2007) Laparoscopic retroperitoneal lymph node dissection: technique. BJU Int 100(6):1415–1429
Conflict of interest
We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, and there is no professional or other personal interest of any nature or kind in any product, service, and/or company that could be construed as influencing the position presented in the manuscript.
Minfeng Chen contributed equally to this work with Shiyu Tong.
About this article
Cite this article
Tong, S., Chen, M., Zu, X. et al. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center’s retrospective analysis. Int Urol Nephrol 46, 363–369 (2014). https://doi.org/10.1007/s11255-013-0547-3
- Transperitoneal retroperitoneal lymph node dissection
- Extraperitoneal retroperitoneal lymph node dissection
- Nonseminomatous germ cell testicular tumors